Wells Fargo & Company Issues Pessimistic Forecast for DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target lowered by Wells Fargo & Company from $20.00 to $19.00 in a report released on Friday,Benzinga reports. The brokerage currently has an equal weight rating on the medical instruments supplier’s stock.

A number of other equities research analysts have also weighed in on XRAY. Barrington Research decreased their price objective on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a report on Friday. Leerink Partnrs lowered DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Tuesday, February 18th. Morgan Stanley cut their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research note on Tuesday, December 17th. Finally, Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $30.00 to $20.00 in a research note on Thursday, January 23rd. Eleven equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $23.58.

DENTSPLY SIRONA Price Performance

XRAY opened at $16.55 on Friday. The business has a fifty day moving average of $18.88 and a 200 day moving average of $21.55. The stock has a market cap of $3.29 billion, a P/E ratio of -8.00, a PEG ratio of 1.80 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a 52-week low of $16.21 and a 52-week high of $34.91.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 3.87%. DENTSPLY SIRONA’s payout ratio is -30.92%.

Hedge Funds Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently bought and sold shares of the company. Nordea Investment Management AB boosted its position in shares of DENTSPLY SIRONA by 245.0% in the 4th quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock worth $4,754,000 after purchasing an additional 178,639 shares in the last quarter. JPMorgan Chase & Co. raised its stake in DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock valued at $49,990,000 after buying an additional 1,244,326 shares during the last quarter. Barclays PLC boosted its holdings in DENTSPLY SIRONA by 21.8% in the third quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock worth $8,301,000 after acquiring an additional 54,920 shares in the last quarter. Canvas Wealth Advisors LLC grew its stake in shares of DENTSPLY SIRONA by 126.5% during the fourth quarter. Canvas Wealth Advisors LLC now owns 326,298 shares of the medical instruments supplier’s stock worth $6,245,000 after acquiring an additional 182,234 shares during the last quarter. Finally, Quantinno Capital Management LP increased its holdings in shares of DENTSPLY SIRONA by 276.5% during the third quarter. Quantinno Capital Management LP now owns 116,808 shares of the medical instruments supplier’s stock valued at $3,161,000 after acquiring an additional 85,787 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.